vs
Employers Holdings, Inc.（EIG）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Employers Holdings, Inc.的1.2倍（$197.9M vs $170.5M），REPLIGEN CORP同比增速更快（13.6% vs -21.3%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -11.4%）
Employers Holdings, Inc.是总部位于美国的保险控股企业，主营劳工赔偿保险产品，主要面向美国境内中小微企业客户，同时提供定制化风险管理解决方案，服务覆盖多类中低风险行业，助力客户管控工作场所安全风险、满足员工保障相关合规要求。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
EIG vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.2倍
$170.5M
营收增速更快
RGEN
高出34.9%
-21.3%
两年增速更快
RGEN
近两年复合增速
-11.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $170.5M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | -21.3% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EIGRGEN
| Q1 26 | $170.5M | — | ||
| Q4 25 | $188.5M | $197.9M | ||
| Q3 25 | $239.3M | $188.8M | ||
| Q2 25 | $246.3M | $182.4M | ||
| Q1 25 | $202.6M | $169.2M | ||
| Q4 24 | $216.6M | $174.1M | ||
| Q3 24 | $224.0M | $154.9M | ||
| Q2 24 | $217.0M | $154.1M |
净利润EIGRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $13.3M | ||
| Q3 25 | $-8.3M | $14.9M | ||
| Q2 25 | $29.7M | $14.9M | ||
| Q1 25 | $12.8M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $30.3M | $-654.0K | ||
| Q2 24 | $31.7M | $3.3M |
毛利率EIGRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率EIGRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 9.0% | ||
| Q3 25 | -4.7% | 8.9% | ||
| Q2 25 | 15.0% | 7.6% | ||
| Q1 25 | 7.8% | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | 16.4% | -5.1% | ||
| Q2 24 | 18.4% | 1.0% |
净利率EIGRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 6.7% | ||
| Q3 25 | -3.5% | 7.9% | ||
| Q2 25 | 12.1% | 8.2% | ||
| Q1 25 | 6.3% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 13.5% | -0.4% | ||
| Q2 24 | 14.6% | 2.2% |
每股收益（稀释后）EIGRGEN
| Q1 26 | — | — | ||
| Q4 25 | $-0.93 | $0.24 | ||
| Q3 25 | $-0.36 | $0.26 | ||
| Q2 25 | $1.23 | $0.26 | ||
| Q1 25 | $0.52 | $0.10 | ||
| Q4 24 | $1.14 | $-0.55 | ||
| Q3 24 | $1.21 | $-0.01 | ||
| Q2 24 | $1.25 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $169.9M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $955.7M | $2.1B |
| 总资产 | $3.4B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资EIGRGEN
| Q1 26 | $169.9M | — | ||
| Q4 25 | $169.9M | $767.6M | ||
| Q3 25 | $172.4M | $748.7M | ||
| Q2 25 | $78.1M | $708.9M | ||
| Q1 25 | $100.4M | $697.2M | ||
| Q4 24 | $68.4M | $757.4M | ||
| Q3 24 | $173.9M | $784.0M | ||
| Q2 24 | $126.4M | $809.1M |
总债务EIGRGEN
| Q1 26 | — | — | ||
| Q4 25 | $19.0M | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益EIGRGEN
| Q1 26 | $955.7M | — | ||
| Q4 25 | $955.7M | $2.1B | ||
| Q3 25 | $1.0B | $2.1B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $1.1B | $2.0B | ||
| Q4 24 | $1.1B | $2.0B | ||
| Q3 24 | $1.1B | $2.0B | ||
| Q2 24 | $1.0B | $2.0B |
总资产EIGRGEN
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | $2.9B | ||
| Q3 25 | $3.5B | $2.9B | ||
| Q2 25 | $3.5B | $2.9B | ||
| Q1 25 | $3.6B | $2.9B | ||
| Q4 24 | $3.5B | $2.8B | ||
| Q3 24 | $3.6B | $2.8B | ||
| Q2 24 | $3.5B | $2.9B |
负债/权益比EIGRGEN
| Q1 26 | — | — | ||
| Q4 25 | 0.02× | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流EIGRGEN
| Q1 26 | — | — | ||
| Q4 25 | $44.7M | $25.7M | ||
| Q3 25 | $29.4M | $48.1M | ||
| Q2 25 | $0 | $28.6M | ||
| Q1 25 | $14.6M | $15.0M | ||
| Q4 24 | $76.4M | $39.2M | ||
| Q3 24 | $51.0M | $49.3M | ||
| Q2 24 | $11.7M | $42.2M |
自由现金流EIGRGEN
| Q1 26 | — | — | ||
| Q4 25 | $44.6M | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | $76.3M | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M |
自由现金流率EIGRGEN
| Q1 26 | — | — | ||
| Q4 25 | 23.7% | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | 35.2% | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% |
资本支出强度EIGRGEN
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | 0.0% | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% |
现金转化率EIGRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 0.00× | 1.92× | ||
| Q1 25 | 1.14× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.68× | — | ||
| Q2 24 | 0.37× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
